Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-23-127124
Filing Date
2023-04-28
Accepted
2023-04-28 16:28:27
Documents
18
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d478529d10ka.htm   iXBRL 10-K/A 505357
2 EX-10.4 d478529dex104.htm EX-10.4 17741
3 EX-31.3 d478529dex313.htm EX-31.3 4408
4 EX-31.4 d478529dex314.htm EX-31.4 4276
10 GRAPHIC g478529g0426153711732.jpg GRAPHIC 23310
  Complete submission text file 0001193125-23-127124.txt   862108

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rxdx-20221231.xsd EX-101.SCH 5071
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxdx-20221231_cal.xml EX-101.CAL 756
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxdx-20221231_def.xml EX-101.DEF 1761
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxdx-20221231_lab.xml EX-101.LAB 21728
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxdx-20221231_pre.xml EX-101.PRE 17330
12 EXTRACTED XBRL INSTANCE DOCUMENT d478529d10ka_htm.xml XML 7832
Mailing Address 3050 SCIENCE PARK ROAD SAN DIEGO CA 92121
Business Address 3050 SCIENCE PARK ROAD SAN DIEGO CA 92121 (858) 422-4300
Prometheus Biosciences, Inc. (Filer) CIK: 0001718852 (see all company filings)

EIN.: 814282653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40187 | Film No.: 23866955
SIC: 2834 Pharmaceutical Preparations